Rapid epidemiological mapping of onchocerciasis (REMO):: its application by the African Programme for Onchocerciasis Control (APOC)

被引:91
作者
Noma, M
Nwoke, BEB
Nutall, I
Tambala, PA
Enyong, P
Namsenmo, A
Remme, J
Amazigo, UV
Kale, OO
Sékétéli, A
机构
[1] African Programme Onchocerciasis Control, Ouagadougou 01, Burkina Faso
[2] Imo State Univ, Sch Biol Sci, Owerri, Nigeria
[3] WHO, CH-1211 Geneva 27, Switzerland
[4] Natl Onchocerciasis Task Force, Blantyre, Malawi
[5] Trop Med Res Stn, Kumba, Cameroon
[6] Minist Sante & Populat, Bangui, Cent Afr Republ
[7] Univ Coll Ibadan Hosp, Dept Prevent & Social Med, Ibadan, Nigeria
来源
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY | 2002年 / 96卷
关键词
D O I
10.1179/000349802125000637
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
One of the fundamental challenges that the African Programme for Onchocerciasis Control (APOC) has had to face is how to identify the endemic communities where its mass ivermectin-treatment operations are to be carried out in conformity with its stated objective of targetting the most highly endemic, affected and at-risk populations. This it has done by adopting a technique, known as the rapid epidemiological mapping of onchocerciasis (REMO), that provides data on the distribution and prevalence of onchocerciasis. Integration of the REMO data into a geographical information system (GIS) enables delineation of zones of various levels of endemicity, and this is an important step in the planning process for onchocerciasis control. Zones are included in (or excluded from) the APOC-funded programme of community-directed treatment with ivermectin (CDTI), depending on whether or not their levels of onchocercal endemicity reach the threshold set by APOC. This review describes the application of the REMO/GIS technique by APOC in its operations, and identifies the remaining related challenges.
引用
收藏
页码:29 / 39
页数:11
相关论文
共 24 条
[1]   THE IMPACT OF 5 YEARS OF ANNUAL IVERMECTIN TREATMENT ON SKIN MICROFILARIAL LOADS IN THE ONCHOCERCIASIS FOCUS OF ASUBENDE, GHANA [J].
ALLEY, ES ;
PLAISIER, AP ;
BOATIN, BA ;
DADZIE, KY ;
REMME, J ;
ZERBO, G ;
SAMBA, EM .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 (05) :581-584
[2]   IVERMECTIN TREATMENT IN SEVERE ASYMMETRIC REACTIVE ONCHODERMATITIS (SOWDA) IN SUDAN [J].
BARAKA, OZ ;
MAHMOUD, BM ;
ALI, MMM ;
ALI, MH ;
ELSHEIKH, EA ;
HOMEIDA, MMA ;
MACKENZIE, CD ;
WILLIAMS, JF .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1995, 89 (03) :312-315
[3]  
Benton B, 1998, ANN TROP MED PARASIT, V92, pS33, DOI 10.1080/00034989859537
[4]   Three probable cases of Loa Loa encephalopathy following ivermectin treatment for onchocerciasis [J].
Boussinesq, M ;
Gardon, J ;
Gardon-Wendel, N ;
Kamgno, J ;
Ngoumou, P ;
Chippaux, JP .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (04) :461-469
[5]   Ivermectin where Loa loa is endemic [J].
Burnham, GM .
LANCET, 1997, 350 (9070) :2-3
[6]   Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas [J].
Chippaux, JP ;
Boussinesq, M ;
Gardon, J ;
GardonWendel, N ;
Ernould, JC .
PARASITOLOGY TODAY, 1996, 12 (11) :448-450
[7]   DETAILED EPIDEMIOLOGIC MAPPING OF 3 ONCHOCERCIASIS FOCI IN WEST AFRICA [J].
DESOLE, G ;
GIESE, J ;
KEITA, FM ;
REMME, J .
ACTA TROPICA, 1991, 48 (03) :203-213
[8]  
DESOLE G, 1991, B WORLD HEALTH ORGAN, V69, P689
[9]  
LEBERRE R, 1966, MEMOIRE ORSTOM, V17
[10]  
NGOUMOU B, 1993, TDRTDEONCHO934 WHO